# Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension

> **NCT04952051** · PHASE3 · COMPLETED · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 1000 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Enalapril Folic Acid Tablets Combined With amlodipine
- **DRUG:** Enalapril Folic Acid Tablets Combined With hydrochlorothiazide

## Key facts

- **NCT ID:** NCT04952051
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-01
- **Primary completion:** 2019-07-31
- **Final completion:** 2020-07-01
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2021-07-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04952051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04952051, "Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04952051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*